Literature DB >> 20483181

CA125 and immunoinflammatory activity in acute heart failure.

Gema Miñana, Julio Núñez, Juan Sanchis, Vicent Bodí, Eduardo Núñez, Angel Llàcer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20483181     DOI： 10.1016/j.ijcard.2010.04.081

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

Review 1.  Clinical utility of antigen carbohydrate 125 in heart failure.

Authors:  Julio Núñez; Gema Miñana; Eduardo Núñez; Francisco J Chorro; Vicent Bodí; Juan Sanchis
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

2.  Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Hiroyuki Naito; Shiro Aoki; Tsuyoshi Torii; Takashi Kurashige; Tomohito Sugiura; Daisuke Kuzume; Yuko Morimoto; Takeshi Yoshida; Yoshiki Yagita; Naoki Oyama; Yuji Shiga; Naoto Kinoshita; Teppei Kamimura; Hiroki Ueno; Tomohiko Ohshita; Hirofumi Maruyama
Journal:  Intern Emerg Med       Date:  2021-10-01       Impact factor: 3.397

3.  Cancer antigen-125 and outcomes in acute heart failure: a systematic review and meta-analysis.

Authors:  Ka Hou Christien Li; Mengqi Gong; Guangping Li; Adrian Baranchuk; Tong Liu; Martin C S Wong; Aaron Jesuthasan; Rachel W C Lai; Jenny Chi Ling Lai; Alex Pui Wai Lee; Antoni Bayés-Genis; Rafael de la Espriella; Juan Sanchis; William K K Wu; Gary Tse; Julio Nuñez
Journal:  Heart Asia       Date:  2018-10-26

4.  Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.

Authors:  Julio Núñez; Gabriel A Rabinovich; Justo Sandino; Luis Mainar; Patricia Palau; Enrique Santas; Maria Pilar Villanueva; Eduardo Núñez; Vicent Bodí; Francisco J Chorro; Gema Miñana; Juan Sanchis
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Evaluation of CA125 and NT-proBNP values in patients undergoing transcatheter aortic valve implantation.

Authors:  Hüseyin Ayhan; Hacı Ahmet Kasapkara; Tahir Durmaz; Telat Keleş; Cenk Sarı; Serdal Baştuğ; Kemal Eşref Erdoğan; Nihal Akar Bayram; Emine Bilen; Murat Akçay; Engin Bozkurt
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

6.  Beyond malignancy: the role of carbohydrate antigen 125 in heart failure.

Authors:  Chung-Lieh Hung; Ta-Chuan Hung; Yau-Hui Lai; Chi-Sheng Lu; Yih-Jer Wu; Hung-I Yeh
Journal:  Biomark Res       Date:  2013-08-30

7.  Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction.

Authors:  Gema Miñana; Rafael de la Espriella; Patricia Palau; Pau Llácer; Eduardo Núñez; Enrique Santas; Ernesto Valero; Miguel Lorenzo; Gonzalo Núñez; Vicente Bodí; Raquel Heredia; Juan Sanchis; Antoni Bayés-Genís; Francisco J Chorro; Julio Núñez
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

8.  Elevated CA-125 as Humoral Biomarker of Congestive Heart Failure: Illustrative Cases and a Short Review of Literature.

Authors:  Attila Frigy; Boglárka Belényi; Ádám Kirchmaier; Nándor Fekete; István Adorján Szabó
Journal:  Case Rep Cardiol       Date:  2020-05-24

Review 9.  Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure.

Authors:  Marko Kumric; Tina Ticinovic Kurir; Josko Bozic; Duska Glavas; Tina Saric; Bjørnar Marcelius; Domenico D'Amario; Josip A Borovac
Journal:  Card Fail Rev       Date:  2021-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.